首页> 外文期刊>The biochemical journal >Differential interactions of human kallikrein-binding protein and α1-antitrypsin with human tissue kallikrein
【24h】

Differential interactions of human kallikrein-binding protein and α1-antitrypsin with human tissue kallikrein

机译:人激肽释放酶结合蛋白和α1-抗胰蛋白酶与人组织激肽释放酶的相互作用

获取原文
       

摘要

pThe characteristics of a new kallikrein-binding protein in human serum and its activities were studied. Both the kallikrein-binding protein and alpha 1-antitrypsin form 92 kDa SDS-stable and heat-stable complexes with human tissue kallikrein. In non-SDS/PAGE, the mobility of these complexes differ. Complex-formation between kallikrein and the binding protein is inhibited by heparin, whereas that between kallikrein and alpha 1-antitrypsin is heparin-resistant. In normal or alpha 1-antitrypsin-deficient-serum, the amount of 92 kDa SDS-stable complex formed upon addition of kallikrein is not related to serum alpha 1-antitrypsin levels. The rate of complex-formation between kallikrein and the binding protein is 12 times higher than that between kallikrein and alpha 1-antitrypsin. Purified alpha 1-antitrypsin, which exhibits normal elastase binding, has a kallikrein-binding activity less than 5% of that of serum. Binding of tissue kallikrein in serum is not inhibited by increasing elastase concentrations, and elastase binding in serum is not inhibited by excess tissue kallikrein. A specific monoclonal antibody to human alpha 1-antitrypsin does not bind to either 92 kDa endogenous or exogenous kallikrein complexes isolated from human serum. The studies demonstrate a new tissue kallikrein-binding protein, distinct from alpha 1-antitrypsin, is present in human serum./p
机译:>研究了人血清中一种新的激肽释放酶结合蛋白的特性及其活性。激肽释放酶结合蛋白和α1-抗胰蛋白酶都与人组织激肽释放酶形成92 kDa SDS稳定和热稳定的复合物。在非SDS / PAGE中,这些复合物的迁移率不同。肝素抑制激肽释放酶和结合蛋白之间的复合物形成,而激肽释放酶和α1-抗胰蛋白酶之间的复合物形成具有肝素抗性。在正常或α1-抗胰蛋白酶缺乏血清中,加入激肽释放酶后形成的92 kDa SDS稳定复合物的量与血清α1-抗胰蛋白酶水平无关。激肽释放酶和结合蛋白之间的复合物形成速率比激肽释放酶和α1-抗胰蛋白酶之间的复合物形成速率高12倍。表现出正常弹性蛋白酶结合作用的纯化的α1-抗胰蛋白酶的激肽释放酶结合活性低于血清的5%。弹性蛋白酶浓度的增加不会抑制组织激肽释放酶在血清中的结合,而过量的组织激肽释放酶不会抑制血清中的弹性蛋白酶结合。针对人α1-抗胰蛋白酶的特异性单克隆抗体不与从人血清中分离的92 kDa内源性或外源性激肽释放酶复合物结合。研究表明,人血清中存在一种不同于α1-抗胰蛋白酶的组织激肽释放酶结合蛋白。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号